Septo-optic dysplasia

From Wikipedia, the free encyclopedia

Septo-optic dysplasia
Classification & external resources
ICD-10 Q04.4
OMIM 182230
DiseasesDB 32732

Septo-optic dysplasia (SOD) (de Morsier syndrome) is a congenital malformation syndrome manifested by hypoplasia (underdevelopment) of the optic nerve, hypopituitarism, and absence of the septum pellucidum (a midline part of the brain). In a severe case, this results in pituitary hormone deficiencies, blindness, and mental retardation. However, there are milder degrees of each of the three problems, and some children only have one or two of the three.

Neuroradiologically, intracranial malformations associated with septo-optic dysplasia include agenesis of the corpus callosum, schizencephaly, and lobar holoprosencephaly.

The optic nerve hypoplasia is generally manifested by nystagmus (involuntary eye movements, often side-to-side) and a smaller-than-usual optic disk. The degree of visual impairment is variable, and ranges from normal vision to complete blindness. When nystagmus develops, it typically appears by 1-4 months of age, and usually indicates that there will be a significant degree of visual impairment, but the severity is difficult to predict in infancy. Although there are many measures to compensate for visual impairment, no treatment is available to induce normal optic nerve function.

The degree of pituitary deficiency is also variable, and ranges from normal function, to deficiency of a single hormone, to deficiency of both anterior and posterior hormones (termed panhypopituitarism). Hypopituitarism in this syndrome is most often manifested by growth hormone deficiency. If severe, it can lead to diagnosis in the first days of life by causing hypoglycemia, jaundice, and micropenis (if a boy). The cause of the jaundice is unknown, and an unusual aspect of it (compared to most neonatal jaundice) is that it can be largely a conjugated (direct) hyperbilirubinemia suggested of obstructive liver disease. It typically resolves over several weeks once hormone replacement is begun. All of the pituitary hormones can be replaced, and this is the treatment for deficiencies. Septo-optic dysplasia is one of the most common forms of congenital growth hormone deficiency.

The brain effects are also variable and range from normal intelligence to severe mental retardation. Seizures sometimes occur. Prediction of intellectual outcome in infancy is difficult. Various types of early intervention or equivalent programs can help a child reach full developmental potential, but if brain impairment is significant, it cannot be made normal by any treatment.

The cause of septo-optic dysplasia is not known. Rare familial recurrence has been reported, suggesting at least one genetic form, but in most cases it is a sporadic birth defect of unknown cause and does not recur again with subsequent pregnancies.

[edit] External links